Search News Releases
American Heart Association council honors New York cardiologist for important contributions in the field of ischemic heart disease
The American Heart Association Council on Clinical Cardiology presented its James B. Herrick Award for Outstanding Achievement in Clinical Cardiology to Judith S. Hochman, M.D., of New York University School of Medicine in New York City, “for her important contributions in the field of ischemic heart disease throughout a distinguished career.”
Director of NHLBI receives American Heart Association Research Achievement Award for “dynamic leadership” of heart studies, especially among minorities
The American Heart Association (AHA) today presented its 2018 Research Achievement Award to Gary Gibbons, M.D., director of the National Heart, Lung and Blood Institute, “for his dynamic leadership of studies of cardiovascular health and disease, especially in minority populations.”
AHA Population Research Prize goes to Vermont medical scientist for use of “biomarkers” to expand understanding of cardiovascular disease causes
The American Heart Association has awarded its Population Research Prize for 2018 to Mary Cushman, M.D., of the Larner College of Medicine at the University of Vermont in Burlington, “for contributions to our understanding of the causes of cardiovascular diseases, including heart disease, venous thrombosis, stroke and risk factors for these diseases, with emphasis on understanding racial disparities.”
Duke University School of Medicine official given AHA award for his ‘intense dedication’ to teaching, mentoring trainees
The American Heart Association (AHA) has presented its Eugene Braunwald Academic Mentorship Award to Robert M. Califf, M.D., of the Duke University School of Medicine, “for his intense dedication to the successful teaching and mentoring of a legion of trainees and clinicians who have gone on to engage in a worldwide assault on cardiovascular diseases through the integration of research, education and clinical practice.”
Harvard scientist gets American Heart Association award for findings of inherited basis for cardiovascular disorders
The American Heart Association has presented its Joseph A. Vita Award to Sekar Kathiresan, M.D., of Massachusetts General Hospital (MGH) and Harvard Medical School in Boston, “for his highly significant discoveries elucidating the inherited basis for a cardiovascular disease, particularly early heart attack, and translating these findings into biological and therapeutic insights.”
Quest Diagnostics to accelerate cardiovascular disease biomarker discovery as part of One Brave Idea™ initiative to end coronary heart disease
Developing novel approaches to understand cardiovascular health and pre-disease is the cornerstone strategy of One Brave Idea™, a research initiative led by Dr. Calum MacRae, vice chair for Scientific Innovation in the department of Medicine at Brigham and Women's Hospital.
American Heart Association looks beyond heart disease and stroke to improve overall health and well-being globally
DALLAS, Nov. 11, 2018 — As heart disease and stroke continue to claim more lives worldwide than all other causes, the American Heart Association is boldly growing beyond borders and its core business to advance health and well-being across the globe....
Guías actualizadas para el tratamiento del colesterol ofrecen una evaluación de riesgo más personalizada y opciones de tratamiento adicionales para las personas que corren el riesgo más alto
Aspectos destacados de la declaración: Los niveles altos de colesterol pueden aumentar el riesgo de una persona de padecer cardiopatías y derrames cerebrales durante su vida, sin importar su edad. El primer paso para prevenir y reducir este riesgo es adoptar un estilo de vida saludable. Las guías de 2018 recomiendan evaluaciones de riesgo más detalladas para ayudar a los profesionales de salud a determinar de manera más adecuada el riesgo individual de cada persona y las opciones de tratamiento. En algunos casos, el índice de calcio en las arterias coronarias puede ayudar a determinar si una persona necesita un tratamiento para reducir el colesterol, en caso de que la situación de riesgo sea dudosa o si la decisión sobre el tratamiento no está clara.
Updated cholesterol guidelines offer more personalized risk assessment, additional treatment options for people at the highest risk
Statement Highlights: High cholesterol, at any age, can increase a person’s lifetime risk for heart disease and stroke. A healthy lifestyle is the first step in prevention and treatment to lower that risk. The 2018 guidelines recommend more detailed risk assessments to help health care providers better determine a person’s individualized risk and treatment options. In some cases, a coronary artery calcium score can help determine a person’s need for cholesterol-lowering treatment, if their risk status is uncertain or if the treatment decision isn't clear.
To Address Youth E-Cigarette Epidemic, FDA Must Stop Sales of All Flavored Products and Restrict Marketing and Sales to Protect Kids
According to reports by The Washington Post and other media, the Food and Drug Administration plans to announce limitations on the sale of certain flavored electronic cigarettes in convenience stores and gas stations, restricting the sale of the affected products to tobacco and vape shops.